We’re already in it. We’re starting to deploy phages (viruses engineered to infect specific pathogenic bacteria) to target bacterial infections which don’t cause the significant collateral damage to the human biome that antibiotics do. Phages are harder for bacteria to develop resistance to.
Between phages, mRNA vaccines, and new methods of drug manufacturing, we are entering an era where ending communicable disease is within the realm of possibility.
1 Comment
We’re already in it. We’re starting to deploy phages (viruses engineered to infect specific pathogenic bacteria) to target bacterial infections which don’t cause the significant collateral damage to the human biome that antibiotics do. Phages are harder for bacteria to develop resistance to.
Between phages, mRNA vaccines, and new methods of drug manufacturing, we are entering an era where ending communicable disease is within the realm of possibility.